You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Subfoveal Choroidal Neovascularization

Showing 1 - 25 of 952
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Australia

Completed
  • Age-related Macular Degeneration
  • +2 more
  • bevacizumab
  • ranibizumab
  • Hurstville, New South Wales, Australia
  • +8 more
May 7, 2021

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • +2 more
  • Intravitreal aflibercept injection
  • Seoul, Korea, Republic of
    Jae Hui Kim
Dec 20, 2022

Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)

Completed
  • Pathologic Myopia
  • Intravitreal injection
  • Mykolaiv, Ukraine
  • +2 more
Jan 23, 2023

Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States

Completed
  • Age-related Macular Degeneration
  • +2 more
  • bevacizumab
  • ranibizumab
  • Tucson, Arizona
  • +49 more
Feb 15, 2022

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • +2 more
  • BD311
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Aug 22, 2022

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)

    Completed
    • Choroidal Neovascularization
    • Sao Paulo, Brazil
      Hospital das Clínicas- University of Sao Paulo
    Jan 4, 2022

    Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling Trial in Salt Lake City (Early disclosure,

    Completed
    • Age-Related Macular Degeneration
    • +2 more
    • Early disclosure
    • Late disclosure
    • Salt Lake City, Utah
      University of Utah John A. Moran Eye Center
    Aug 10, 2022

    Myopic Choroidal Neovascularisation Trial in Guangzhou (3+PRN, 6+PRN)

    Recruiting
    • Myopic Choroidal Neovascularisation
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Feb 8, 2022

    Deep Learning OCT and OCTA in NVC

    Recruiting
    • Macular Degeneration Choroidal Neovascularization
    • Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
    • Naples, Italy
      Federico II University
    Aug 3, 2023

    Learn More About How Drug Aflibercept Works in Canadian Reduced

    Active, not recruiting
    • Myopic Choroidal Neovascularization
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Canada
      Many Locations
    Jul 25, 2022

    Optical Coherence Tomography Angiography Criteria Of The

    Not yet recruiting
    • Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
    • Optical coherence tomography angiography
    • (no location specified)
    Sep 27, 2022

    Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial

    Recruiting
    • Diabetic Macular Edema
    • +4 more
    • Anti-vascular endothelial growth factors (Anti-VEGFs)
    • Banhā, Benha, Egypt
      Ahmed Abdelshafy Tabl
    Aug 8, 2022

    Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

    Not yet recruiting
    • Macular Degeneration, Age Related
    • +4 more
    • VISUPRIME
    • Placebo
    • Perugia, PG, Italy
      Ospedale Santa Maria della Misericordia
    Dec 22, 2022

    Real Life Study in Myopic Neovascularization

    Active, not recruiting
    • Myopic Choroidal Neovascularisation
    • AFLIBERCEPT
    • Poitiers, France
      Chu de Poitiers
    Sep 28, 2021

    OCTA Insights in CNVM, Morphological Characteristics and

    Not yet recruiting
    • Choroidal Neovascularization
      • (no location specified)
      Sep 14, 2021

      Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)

      Recruiting
      • Pathologic Myopia
      • Intravitreal injection
      • Lutsk, Ukraine
      • +3 more
      Mar 23, 2022

      Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)

      Recruiting
      • Pathological Myopic Choroidal Neovascularization
      • BeiJing, China
        Peking Union Medical College Hospital
      Jun 4, 2021

      Macular Degeneration, Choroidal Neovascularization Trial in 'Aiea, Oak Forest (episcleral brachytherapy)

      Recruiting
      • Macular Degeneration, Choroidal Neovascularization
      • episcleral brachytherapy
      • 'Aiea, Hawaii
      • +1 more
      Feb 11, 2022

      Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers, Choroidal Neovascularization Trial in Madrid (SYL18001

      Completed
      • Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers
      • Choroidal Neovascularization
      • SYL18001 sodium Low dose q.d
      • +3 more
      • Madrid, Spain
        Sylentis Clinical Trial Site
      Mar 30, 2022

      Myopic Choroidal Neovascularisation Trial in Beijing (CM082)

      Suspended
      • Myopic Choroidal Neovascularisation
      • Beijing, China
        Peking Union Medical College Hospital
      Mar 7, 2021

      Choroidal Neovascularization, Wet Macular Degeneration Trial in United States (ICON-1, aflibercept)

      Terminated
      Has Results
      • Choroidal Neovascularization
      • Wet Macular Degeneration
      • ICON-1
      • aflibercept
      • Beverly Hills, California
      • +7 more
      Mar 21, 2021

      Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])

      Completed
      • Central Retinal Vein Occlusion With Macular Edema
      • Ziv-Aflibercept 25 MG/ML [Zaltrap]
      • Tanta, El Gharbia, Egypt
        Tanta University
      Oct 4, 2021

      Pachychoroid Neovasculopathy Trial (Three monthly injections of intravitreal aflibercept)

      Not yet recruiting
      • Pachychoroid Neovasculopathy
      • Three monthly injections of intravitreal aflibercept
      • (no location specified)
      Dec 14, 2022

      Chorioretinitis Trial in Mykolaiv, Odessa (Intravitreal injection, Fluorescent angiography, Visometry)

      Unknown status
      • Chorioretinitis
      • Intravitreal injection
      • +6 more
      • Mykolaiv, Ukraine
      • +2 more
      Feb 2, 2021